Linius Tech Limited (ASX: LNU) – It is an information technology company that is engaged in commercialization and development of video file technology. The stock was trading at a market price of $0.067 and has seen a daily price change of -$0.001 or a percentage change of -1.471% as at August 20, 2018, 2:50 PM AEST. The stock has undergone a performance change of 36.00% over the past 12 months. Increasing the penetration of virtual video with a target completion date of three to six months, the Company published a list of near-term goals (NTGs), which are intended to drive the long-term goal and revenue.
Ookami Limited (ASX: OOK) has engaged itself in a blockchain venture and into unique financial services software and SaaS technologies; and its stock was trading at a current market price of $0.024 and has seen a daily price change of $0.001 or a percentage change of 4.348% as at August 20, 2018, 2:50 PM AEST. The stock has undergone a performance change of 64.29% over the past 12 months. The company with NCX has completed software architecture and business analysis scoping exercise. To provide and implement its secure cryptocurrency to BPAY/Bank account technologies as Payment Gateway solution, Ookami reached an agreement with ‘Paid by Coins’. The directors continue to consider technologies and solutions for future growth.
First Growth Funds Ltd (ASX: FGF) is an LIC that has undertaken a placement for investment in Blockchain. The stock was trading at a market price of $0.012 and has seen a daily price change of $0.002 or a percentage change of 20% as at August 20, 2018, 2:50 PM AEST. The stock has undergone a performance change of 100% over the past 12 months. Acudeen Technologies that joined hands with FGF, is to list on BTCXA, a digital currency exchange. FGF may also receive additional fees from the sale of tokens while it holds 20% of all tokens. As soon as practical, FGF will seek to convert these tokens to Australian dollars.
Up 22% as at August 20, 2018, 2:50 PM AEST, Genetic Technologies Ltd (ASX: GTG) under the health-care segment, is another name that is engaging in block chain technology for molecular diagnostics. The stock was trading at a market price of $0.011 and has seen a daily price change of $0.002. The stock has undergone a performance change of 28.57% over the past 12 months. The blockchain technologies company has signed a Heads of agreement with Beijing Zishan Health Consultancy Limited. Through this joint venture, both the parties will explore opportunities to achieve market entry into the health sector in the People’s Republic of China. JV will be owned 50-50% by GTG and Zishan and its associated entities.
The Income available from dividends remains attractive for many investors.
We take a look at the best yields on the market and assess what they say about a company’s prospect.
One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”
ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.
Click here to get your free report.
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.